Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
October 3, 2019
An R-Derived FlowSOM Process to Analyze Unsupervised Clustering of Normal and Malignant Human Bone Marrow Classical Flow Cytometry Data
Francis Lacombe, Nicolas Lechevalier, Jean Philippe Vial, et al.
Cancers
|
February 10, 2021
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia
Jean Philippe Vial, Nicolas Lechevalier, Francis Lacombe, et al.
Annales De Biologie Clinique
|
October 21, 2023
Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patients
Victor-Emmanuel Brett, Marie-Sarah Dilhuydy, Nicolas Lechevalier, et al.
American Journal of Clinical Pathology
|
November 2, 2018
Reference Values for WBC Differential by Hematoflow Analysis
Marion Magierowicz, Nicolas Lechevalier, Nicolas Freynet, et al.
Ejhaem
|
February 26, 2024
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia
Céline Row, Nicolas Lechevalier, Jean Philippe Vial, et al.
Leukemia Research
|
January 12, 2024
Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study
Ibrahim Didi, Jean-Marc Alliot, Pierre-Yves Dumas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2022
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia
Alban Canali, Inès Vergnolle, Sarah Bertoli, et al.
Cancer Medicine
|
February 24, 2024
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy
Harmony Leroy, Noémie Gadaud, Emilie Bérard, et al.
Cancers
|
July 30, 2020
Real-World Outcomes of Patients with Refractory or Relapsed <i>FLT3</i>-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study
Pierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.
Cancers
|
March 29, 2020
Outcome of Relapsed or Refractory <i>FLT3</i>-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study
Sarah Bertoli, Pierre-Yves Dumas, Emilie Bérard, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
October 3, 2019
An R-Derived FlowSOM Process to Analyze Unsupervised Clustering of Normal and Malignant Human Bone Marrow Classical Flow Cytometry Data
Francis Lacombe, Nicolas Lechevalier, Jean Philippe Vial, et al.
Cancers
|
February 10, 2021
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia
Jean Philippe Vial, Nicolas Lechevalier, Francis Lacombe, et al.
Annales De Biologie Clinique
|
October 21, 2023
Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patients
Victor-Emmanuel Brett, Marie-Sarah Dilhuydy, Nicolas Lechevalier, et al.
American Journal of Clinical Pathology
|
November 2, 2018
Reference Values for WBC Differential by Hematoflow Analysis
Marion Magierowicz, Nicolas Lechevalier, Nicolas Freynet, et al.
Ejhaem
|
February 26, 2024
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia
Céline Row, Nicolas Lechevalier, Jean Philippe Vial, et al.
Leukemia Research
|
January 12, 2024
Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study
Ibrahim Didi, Jean-Marc Alliot, Pierre-Yves Dumas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2022
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia
Alban Canali, Inès Vergnolle, Sarah Bertoli, et al.
Cancer Medicine
|
February 24, 2024
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy
Harmony Leroy, Noémie Gadaud, Emilie Bérard, et al.
Cancers
|
July 30, 2020
Real-World Outcomes of Patients with Refractory or Relapsed <i>FLT3</i>-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study
Pierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.
Cancers
|
March 29, 2020
Outcome of Relapsed or Refractory <i>FLT3</i>-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study
Sarah Bertoli, Pierre-Yves Dumas, Emilie Bérard, et al.
Page
of 2